TART - Troglitazone Atherosclerosis Regression Trial
NCT00116545
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
288
Enrollment
INDUSTRY
Sponsor class
Conditions
Atherosclerosis
Diabetes Mellitus
Interventions
DRUG:
troglitazone
Sponsor
Parke-Davis